Breast cancer cell line panel - kinase inhibitor drug response model
Cell lines:
BT20BT474
BT549
CAL120
CAL148
CAL51
CAMA1
HCC1187
HCC1395
HCC1419
HCC1500
HCC1569
HCC1806
HCC1937
HCC1954
HCC38
HCC70
HS578T
MCF7
MFM223
MM157
MM231
MM361
MM436
MM453
MM468
SKBR3
SKBR7
T47D
ZR7530
Drugs:
UntreatedAZD8055 (mTORC1/2)
BEZ235 (mTORC1/2, PI3K)
GDC0941 (PI3K)
MK2206 (AKT)
PD0325901 (MEK)
Lapatinib (EGFR, ERBB2)
Foretinib (FGFR2, MET)
Concentration:
current